Pharma & Biotech News #PharmaBuzz

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Weekly News Recap #Phispers

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

In Phispers this week, Indian drugmaker Sun Pharmaceutical acquired Jersey-based Organon in an all-cash deal valued at about US...

Impressions : 1421

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

Eli Lilly has been on an acquisition spree this year. After buying Ventyx Biosciences, Orna Therapeutics, CrossBridge Bio, and...

Impressions : 1371

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

This week’s Phispers brings you news on how artificial intelligence (AI) is taking centerstage in the world of pharmaceut...

Impressions : 2112

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

In Phispers this week, Neurocrine Biosciences announced the acquisition of rare-disease drugmaker Soleno Therapeutics for US$ ...

Impressions : 1342

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

India's Sun Pharma acquires Organon for about US$ 11.75 bn; Lilly to buy Ajax Therapeutics for up to US$ 2.3 bn

Lilly buys biotech Kelonia for up to US$ 7 bn; Trump orders priority review of psychedelic drugs to treat mental illnesses

FDA seeks more safety data from Lilly on obesity drug Foundayo; Novo partners OpenAI to speed up drug development

Neurocrine buys Soleno for US$ 2.9 bn; Novo says Wegovy pill outperforms Lilly's Foundayo in cross-trial comparison

Aizant's Generics Eltrombopag Olamine Receives Approval in US

Sun Pharma Canada's Generics Doxepin HCl Receives Approval in US

Micro's Generics Ticagrelor Receives Approval in US

Astrazeneca's Biologics Saphnelo Receives Approval in US

Alembic's Generics Fingolimod HCl Receives Approval in US

Navinta's Generics Glycerol Phenylbutyrate Receive Approval in US

Teva' Generics Budesonide & Formoterol Receives Approval in US

ScieGen Pharms' Generics Valsartan Receives Approval in US

Hainan's Generics Tigecycline Receives Tentative Approval in US

Cipla's Generics Albuterol Sulfate Receives Approval in US

Intas' Receives FDA Warning Letter

Lexia's Receives FDA Warning Letter

B. Braun Issues Voluntary Recall of Lactated Ringer's Injection

Enforcement Report - Week of April 22, 2026

Veyx-Pharma B.V. Production Fails EDQM Inspection

Produlab Pharma Production Fails EDQM Inspection

Thrive Health and Wellness' Receives FDA Warning Letter

Xiamen Kang Zhongyuan Biotechnology's Receives FDA Warning Letter

Apollo Care's Receives FDA Warning Letter

UCSF Radiopharmaceutical Facility's Receives FDA Warning Letter

Sydnexis To Unveil Phase 3 STAR Trial Data On SYD-101 At ARVO

Rezolute Presents Phase 3 Sunrize Study Results On Ersodetug

FDA Approves Pfizer-Arvinas Breast Cancer Drug Despite Weak Data

Novartis Gets Health Canada Nod For Fabhalta In Adult C3G

Weight-loss drugs may also help cut alcohol intake: Study

US FDA approves Axsome's drug for Alzheimer's-related agitation

Novartis Reveals North Carolina Factory In $23B US Expansion

WHO Delays Pandemic Treaty Amid Pathogen-Sharing Dispute

KFSH, Post-Breakthrough Innovation Is Measured by Repetition

Vector Science Files Patent for Microneedle Intratumoral Platform

GTRI: India Supplies 20% of Global Generics, WTO-Compliant IP

Novo Nordisk Launches Ozempic Oral Pill For Type 2 Diabetes

Aurobindo Pharma's Curateq Receives Health Canada Approval

Apotex First Canadian Pharma Co. To Get Health Canada Approval

U.S. Supreme Court Examines Skinny-label Generics Limits

Dr Reddy's Laboratories Receives Approval From Health Canada

Pfizer Secures Deals to Block Heart Drug Generics Until 2030

Hikma And Amarin's Generic Drug Case Goes To Supreme Court

Novartis Reports Earnings Miss Due To Generic Competition

Pfizer Delays Patent Cliff For Blockbuster Vyndamax

Sydnexis To Unveil Phase 3 STAR Trial Data On SYD-101 At ARVO

Rezolute Presents Phase 3 Sunrize Study Results On Ersodetug

FDA Approves Pfizer-Arvinas Breast Cancer Drug Despite Weak Data

Weight-loss drugs may also help cut alcohol intake: Study

US FDA approves Axsome's drug for Alzheimer's-related agitation

Novartis Reveals North Carolina Factory In $23B US Expansion

Vector Science Files Patent for Microneedle Intratumoral Platform

Restore Vision: RV-001 Optogenetic Therapy Interim Results

Oberland Bio Secures CHF 2.5M Funding To Expand Biotech

New Data Reveals Sof-Skn's Efficacy In Patient Samples

JP Nadda Highlights India's Focus on APIs and Biologics Research

Wanbury Clears Korea FDA Inspection At Patalganga Site

Solara Completes US FDA Inspection At Puducherry Site

RPG Life Sciences Expands API Business, Targets GLP-1 Entry

Formosa Pharma Partners with SERI on Corneal Diseases

Onco-Innovations Scales Up API Materials for PNKP Program

C-Ray Receives FDA Acceptance of Type2 DMF for Copper-64 (Cu-64)

Akums Launches Aztreonam-Avibactam to Fight Resistant Infections

Chinese API Surge Strains Indian Pharma Amid Mideast Crisis

MiKART, Benuvia Partner for Controlled Drug Solutions

InspireMD Initiates Voluntary Recall of CGuard Delivery System

ORS Sales Melt In March After Govt's Stricter Labelling Norms

Patient death prompts FDA pause on Newron's Phase 3 schizophrenia

Leanzene Gummies Under Investigation Avoid Fake Complaints & Risk

House Panel Urges Ban on China Data in FDA Approvals

FDA Proposes Excluding Semaglutide, Tirzepatide, Liraglutide

FDA Warns Three Firms For GMP Violations, Cites Incyte

Lilly Backs Haryana State-Fda Against Counterfeit Medicines

FDA Risk Management Biggest Hurdle For Inspections Under QMSR

Gujarat Government Bolsters Drug And Cosmetics Regulation

KFSH, Post-Breakthrough Innovation Is Measured by Repetition

Smile-Fx Introduces AI Braces System For Predictive Treatment

SafeSpace Global Launches Tennessee AI Center of Excellence